-
公开(公告)号:US20090062200A1
公开(公告)日:2009-03-05
申请号:US12135549
申请日:2008-06-09
CPC分类号: C07K14/71 , A61K38/00 , C07K2319/00
摘要: Nucleic acid molecules encoding fusion proteins which bind and inhibit vascular endothelial growth factor (VEGF). The VEGF-binding fusion proteins are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
摘要翻译: 编码结合并抑制血管内皮生长因子(VEGF)的融合蛋白的核酸分子。 VEGF结合融合蛋白在治疗VEGF相关病症和疾病中是治疗上有用的,并且被特别设计用于局部给予特定器官,组织和/或细胞。
-
公开(公告)号:US20100087632A1
公开(公告)日:2010-04-08
申请号:US12623869
申请日:2009-11-23
IPC分类号: C07K19/00
CPC分类号: C07K14/71 , A61K38/00 , C07K2319/00
摘要: Fusion proteins which bind and inhibit vascular endothelial growth factor (VEGF). The VEGF-binding fusion proteins are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
摘要翻译: 结合并抑制血管内皮生长因子(VEGF)的融合蛋白。 VEGF结合融合蛋白在治疗VEGF相关病症和疾病中是治疗上有用的,并且被特别设计用于局部给予特定器官,组织和/或细胞。
-
公开(公告)号:US07972598B2
公开(公告)日:2011-07-05
申请号:US12623869
申请日:2009-11-23
CPC分类号: C07K14/71 , A61K38/00 , C07K2319/00
摘要: Fusion proteins which bind and inhibit vascular endothelial growth factor (VEGF). The VEGF-binding fusion proteins are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
摘要翻译: 结合并抑制血管内皮生长因子(VEGF)的融合蛋白。 VEGF结合融合蛋白在治疗VEGF相关病症和疾病中是治疗上有用的,并且被特别设计用于局部给予特定器官,组织和/或细胞。
-
公开(公告)号:US07635474B2
公开(公告)日:2009-12-22
申请号:US12135549
申请日:2008-06-09
CPC分类号: C07K14/71 , A61K38/00 , C07K2319/00
摘要: Nucleic acid molecules encoding fusion proteins which bind and inhibit vascular endothelial growth factor (VEGF). The VEGF-binding fusion proteins are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
摘要翻译: 编码结合并抑制血管内皮生长因子(VEGF)的融合蛋白的核酸分子。 VEGF结合融合蛋白在治疗VEGF相关病症和疾病中是治疗上有用的,并且被特别设计用于局部给予特定器官,组织和/或细胞。
-
公开(公告)号:US07306799B2
公开(公告)日:2007-12-11
申请号:US11089803
申请日:2005-03-25
申请人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
发明人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
CPC分类号: C07K14/71 , A61K38/00 , A61K38/179 , C07K14/47 , C07K2319/00 , C07K2319/30
摘要: Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
摘要翻译: 公开了具有改善的药物动力学和改善的组织穿透的修饰的嵌合多肽,其可用于治疗眼睛疾病,包括年龄相关性黄斑变性和糖尿病性视网膜病变。
-
公开(公告)号:US07521049B2
公开(公告)日:2009-04-21
申请号:US11998709
申请日:2007-11-30
申请人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
发明人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
CPC分类号: C07K14/71 , A61K38/00 , A61K38/179 , C07K14/47 , C07K2319/00 , C07K2319/30
摘要: Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
摘要翻译: 公开了具有改善的药物动力学和改善的组织穿透的修饰的嵌合多肽,其可用于治疗眼睛疾病,包括年龄相关性黄斑变性和糖尿病性视网膜病变。
-
公开(公告)号:US07303747B2
公开(公告)日:2007-12-04
申请号:US11218234
申请日:2005-09-01
申请人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
发明人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
CPC分类号: C07K14/71 , A61K38/00 , A61K38/179 , C07K14/47 , C07K2319/00 , C07K2319/30
摘要: Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
-
公开(公告)号:US07087411B2
公开(公告)日:2006-08-08
申请号:US10609775
申请日:2003-06-30
CPC分类号: C07K14/71 , A61K38/00 , C07K2319/00
摘要: Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF). VEGF mini-traps are disclosed which are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
摘要翻译: 能够结合血管内皮生长因子(VEGF)的核酸分子和多聚体蛋白质。 公开了VEGF微型陷阱,其可用于治疗VEGF相关病症和疾病,并且被特别设计用于特定器官,组织和/或细胞的局部给药。
-
公开(公告)号:US20080220004A1
公开(公告)日:2008-09-11
申请号:US11998709
申请日:2007-11-30
申请人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
发明人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
IPC分类号: A61K39/395 , A61K38/02
CPC分类号: C07K14/71 , A61K38/00 , A61K38/179 , C07K14/47 , C07K2319/00 , C07K2319/30
摘要: Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
摘要翻译: 公开了具有改善的药物动力学和改善的组织穿透的修饰的嵌合多肽,其可用于治疗眼睛疾病,包括年龄相关性黄斑变性和糖尿病性视网膜病变。
-
10.
公开(公告)号:US07399612B2
公开(公告)日:2008-07-15
申请号:US11346008
申请日:2006-02-02
摘要: Nucleic acid molecules encoding fusion proteins which bind and inhibit vascular endothelial growth factor (VEGF). The VEGF-binding fusion proteins are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
摘要翻译: 编码结合并抑制血管内皮生长因子(VEGF)的融合蛋白的核酸分子。 VEGF结合融合蛋白在治疗VEGF相关病症和疾病中是治疗上有用的,并且被特别设计用于局部给予特定器官,组织和/或细胞。
-
-
-
-
-
-
-
-
-